HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Narumi Selected Research

KT 1 (KT-1)

7/2001Development of interferon-alpha resistant subline from human chronic myelogenous leukemia cell line KT-1.
1/2000Sensitivity to interferon-alpha and interferon-stimulated gene factor 3 binding activity in human chronic myelogenous leukemia cell line KT-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Narumi Research Topics

Disease

2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2001 - 01/2000
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
11/2012
1Large Granular Lymphocytic Leukemia
01/2004
1Leukemia
01/2004
1Lymphoma (Lymphomas)
01/2004
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2004
1Neoplasms (Cancer)
07/2001
1Hematologic Neoplasms (Hematological Malignancy)
07/2001

Drug/Important Bio-Agent (IBA)

2KT 1 (KT-1)IBA
07/2001 - 01/2000
2Interferon-alpha (Interferon Alfa)IBA
07/2001 - 01/2000
1Valsartan (Vals)FDA Link
11/2012
1Interferon-Stimulated Gene Factor 3IBA
01/2000
1InterferonsIBA
01/2000

Therapy/Procedure

1Homologous Transplantation
01/2004
1Transplantation
01/2004
1Stem Cell Transplantation
01/2004
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2004